- Home
- HUT vs IDYA Comparison
HUT vs IDYA Comparison
Compare HUT & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUT
- IDYA
- Stock Information
- Founded
- HUT 2011
- IDYA 2015
- Country
- HUT United States
- IDYA United States
- Employees
- HUT N/A
- IDYA N/A
- Industry
- HUT Finance: Consumer Services
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- HUT Finance
- IDYA Health Care
- Exchange
- HUT Nasdaq
- IDYA Nasdaq
- Market Cap
- HUT 1.8B
- IDYA 2.0B
- IPO Year
- HUT N/A
- IDYA 2019
- Fundamental
- Price
- HUT $13.57
- IDYA $18.01
- Analyst Decision
- HUT Strong Buy
- IDYA Strong Buy
- Analyst Count
- HUT 9
- IDYA 13
- Target Price
- HUT $31.89
- IDYA $53.58
- AVG Volume (30 Days)
- HUT 4.4M
- IDYA 859.0K
- Earning Date
- HUT 03-03-2025
- IDYA 05-06-2025
- Dividend Yield
- HUT N/A
- IDYA N/A
- EPS Growth
- HUT 647.35
- IDYA N/A
- EPS
- HUT 3.33
- IDYA N/A
- Revenue
- HUT $162,385,000.00
- IDYA $7,000,000.00
- Revenue This Year
- HUT $74.79
- IDYA $89.14
- Revenue Next Year
- HUT $116.78
- IDYA $291.34
- P/E Ratio
- HUT $4.10
- IDYA N/A
- Revenue Growth
- HUT 69.07
- IDYA N/A
- 52 Week Low
- HUT $6.95
- IDYA $16.95
- 52 Week High
- HUT $31.95
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- HUT 42.04
- IDYA 37.17
- Support Level
- HUT $12.37
- IDYA $16.95
- Resistance Level
- HUT $14.01
- IDYA $18.90
- Average True Range (ATR)
- HUT 0.94
- IDYA 0.95
- MACD
- HUT 0.43
- IDYA 0.11
- Stochastic Oscillator
- HUT 71.30
- IDYA 38.97
About HUT Hut 8 Corp.
Hut 8 Corp is engaged in the mining of digital assets with an operational focus on utilizing specialized equipment to solve complex computational problems to validate transactions on the Bitcoin blockchain and receiving Bitcoin in return for successful services. The company has four reportable business segments: Digital Assets Mining, Managed Services, High Performance Computing -Colocation and Cloud, and Other. It derives maximum revenue from Digital Assets Mining segment.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.